Arcturus Therapeutics Expands Operations Campus In San Diego, California
11/04/2014
Founded in 2013, Arcturus Therapeutics is focused on RNA medicines for the treatment of rare diseases. Arcturus has developed a novel, potent and safe RNA Therapeutics platform called LUNAR, a proprietary lipid-enabled delivery system for RNA medicines including small interfering RNA, messenger RNA, antisense, and microRNA oligotherapeutics. The company owns Unlocked Nucleic Acid chemistry technology and patent portfolio enabling the targeting of any gene in the human genome.
"The Arcturus story began at the cutting edge Johnson and Johnson Innovation Center here in San Diego. Today, we are 'graduating' from the incubator space and moving into top-tier facilities that will enable us to execute our vision of bringing transformational life-saving RNA medicines to patients," said Joseph E. Payne, President/CEO of Arcturus Therapeutics, Inc. "We are expanding our work force and hiring key individuals to help us develop premier RNA medicines, such as our lead rare disease drug candidate, LUNAR-101, for treatment of transthyretin-mediated amyloidosis."
"San Diego is a city of innovation. Arcturus Therapeutics is an excellent example of the region's entrepreneurial spirit. Outstanding high-growth biotechnology companies like Arcturus are making us a global leader in technological breakthroughs while also providing high quality jobs for San Diegans here at home," said San Diego Mayor Kevin Faulconer.
Project Announcements
Huber Engineered Woods Plans Shuqualak, Mississippi, Manufacturing Plant
06/09/2023
Gaffney Bakery Plans Gaffney, South Carolina, Frozen Bakery Products Plant
06/09/2023
Itron Establishes West Union, South Carolina, Center Of Excellence
06/09/2023
Devele Establishes Butte, Montana, Manufacturing Plant
06/09/2023
Manner Polymers Plans Mount Vernon, Illinois, Manufacturing Plant
06/09/2023
Purolite Establishes Landenberg, Pennsylvania, Global Biologics Division
06/08/2023
Most Read
-
EV and Semiconductor Projects Stand Out in States Receiving Area Development’s 18th Annual Shovel Awards
Q2 2023
-
37th Annual Corporate Survey: Economic Pressures Exerting Greatest Effect on Decision-Makers
Q1 2023
-
Is a Flurry of Fads Shaping Economic Development Policy?
Q2 2023
-
Front Line: Water Supply Increasingly Affecting Location Decisions
Q2 2023
-
Life Science Conversions in Real Estate
Q2 2023
-
Nearshoring — North America’s Next Factory
Q2 2023
-
First Person: Labor Crunch in the Construction Industry
Q2 2023